AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Recursion’s 2026 Update Suggests a Strategic Recalibration
Recursion’s 2026 update and board shift have prompted fresh questions about its AI drug discovery strategy. The changes may reflect a company adapting its ambitions to the realities of building a sustainable platform business in biotech.
AI in Drug Discovery: 2025 in Review — Insilico Medicine Hits Phase IIa Milestone
Insilico Medicine achieved the first positive Phase IIa results for a fully AI-designed drug, while the Recursion-Exscientia merger created an end-to-end AI drug discovery platform. Over 200 AI-discovered drugs are now in development.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.